Dolasetron Injection and Histrelin: Interaction Details

Brand names
Dolasetron Injection
Anzemet
Histrelin
Supprelin
Same medicines, other forms
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page

A close look at the Dolasetron Injection and Histrelin interaction:

Share

Share this interaction

Dolasetron Injection

Brand name
  • Anzemet

We don't have a drug information page for Dolasetron Injection yet. Have a question about Dolasetron Injection? Ask a pharmacist, free →

Histrelin

Brand name
  • Supprelin

We don't have a drug information page for Histrelin yet. Have a question about Histrelin? Ask a pharmacist, free →

What Happens When You Take Dolasetron Injection With Histrelin

What can happen when they are taken together (rated Major)

Increased risk of

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

Using histrelin together with other drugs that prolong the results in effects on that interval. Androgen deprivation produced by GnRH or can itself lengthen the QT interval.

For patients with congenital long QT syndrome, congestive heart failure, or frequent electrolyte abnormalities, and for those receiving drugs known to prolong the QT interval, weigh whether the benefits of androgen deprivation therapy such as histrelin outweigh the possible risks.3 Whenever possible, avoid combining histrelin with agents that prolong QT. When cannot be avoided, do not use drugs that provoke electrolyte disturbances (ie, or ),1 correct any existing electrolyte abnormalities, and consider periodic and electrolyte monitoring.3

The Dolasetron Injection and Histrelin Interaction, Explained

Both of these medicines can affect your heart's electrical rhythm in a small way. Dolasetron is used to prevent nausea and vomiting. Histrelin is a hormone-lowering medicine, and lowering sex hormones can slightly lengthen the heart's recharge time, called the . Taken together, those effects can add up and raise the chance of an abnormal heart rhythm.

This is a theoretical concern based on how the drugs work, and it doesn't mean problems are likely. Keep taking both as prescribed. Tell your pharmacist or doctor about any heart rhythm problems, heart failure, or low potassium or magnesium. Your care team can weigh the benefits, check your electrolytes, and may do heart tracings (ECGs) if needed. Let them know right away if you feel faint, dizzy, or have a racing or fluttering heartbeat.

Interaction: (). Evidence is theoretical; severity on file is major; onset unspecified.

  • Mechanism: androgen deprivation therapy (GnRH ) may prolong the , and dolasetron (via its active ) also prolongs QT in a dose-related fashion. The effects are additive, with no PK interaction implied.
  • Higher risk: congenital long QT syndrome, CHF, and frequent electrolyte abnormalities.
  • Management: weigh the benefit of ADT against the risk. Avoid with QT-prolonging agents when possible. If coadministration is required, avoid agents that cause or , correct electrolytes, and consider periodic and electrolyte monitoring.

See the 3 references behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Dolasetron Injection and Histrelin Interact

The likely mechanism

In short: Dolasetron injection and histrelin both lengthen the QT interval, a measure of the heart’s rhythm, so taken together the effect can add up.
How Drug Interactions Work See this kind of interaction drawn out, step by step, in “When Effects Add Up or Cancel Out”, one chapter of our one-minute explainer. See how it works 

How to Manage the Dolasetron Injection and Histrelin Interaction

Your care team can manage this, and the first step is making sure the combination is truly needed.

  • Keep taking both medicines as prescribed unless your prescriber tells you otherwise.
  • Your team may weigh the benefits of histrelin against the risks, especially if you have a heart rhythm condition, heart failure, or often have low potassium or magnesium.
  • They may avoid other medicines that lower these minerals, correct any low levels, and monitor you more closely with ECGs and blood tests.
  • Tell your pharmacist or doctor about all your medicines and any fainting, dizziness, or palpitations.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Dolasetron Injection or Histrelin need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Literature Reports

1 report from the published literature. Each one is headed by the title of the published study it comes from.

What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.

  1. Report 1 · Study title

    Androgenic effects on ventricular repolarization: a translational study from the international pharmacovigilance database to iPSC-cardiomyocytes

    A study of male patients receiving androgen deprivation therapy (ADT) analyzed individual case safety reports in VigiBase, the international pharmacovigilance database, and identified 184 cases of acquired long-QT syndrome (aLQTS) and/or (TdP; 11% fatal) and 99 cases of sudden death associated with ADT. Most ADT-associated cases of aLQTS/TdP (62%) and sudden death (88%) occurred without exposure to other drugs known to increase TdP risk.

    However, some aLQTS/TdP events (23% or 43%) and some sudden death events (18% and 22%) involved exposure to 1 drug and to 2 or more drugs, respectively, with conditional, possible, or known TdP risk. The drugs classed as ADTs were abiraterone, gonadotropin-releasing hormone and , nonsteroidal androgen receptor indicated for prostate cancer, and 5-alpha-reductase inhibitors indicated for androgenic alopecia and prostatism.

    Of the 10 ADTs evaluated, 7 showed a disproportional association (reporting odds ratio, 1.4 to 4.7) with aLQTS, TdP, or sudden death: leuprorelin, goserelin, triptorelin, degarelix, bicalutamide, finasteride, and dutasteride. The median patient age was about 76 years.

    The median time to onset was 170 days (range, 7 to 4884 days) for aLQTS/TdP events and 92 days (range, 0.25 to 4984 days) for sudden death events. Patients were receiving ADT mainly for prostate cancer, and some were treated for prostatism and androgenic alopecia. Most patients were on ADT monotherapy (83%), while 17% were receiving ADT combination therapy.2

Dolasetron Injection and Histrelin: Common Questions

How serious is the Dolasetron Injection and Histrelin interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How is the Dolasetron Injection and Histrelin interaction managed?

Your care team can manage this, and the first step is making sure the combination is truly needed. Keep taking both medicines as prescribed unless your prescriber tells you otherwise. Your team may weigh the benefits of histrelin against the risks, especially if you have a heart rhythm condition, heart failure, or often have low potassium or magnesium. They may avoid other medicines that lower the… Management is individual — always follow your own care team's guidance.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

Ask About the Dolasetron Injection and Histrelin Interaction

Ask in your own words about taking Dolasetron Injection and Histrelin together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (3)

  1. Lyon AR, Lopez-Fernandez T, Couch LS, et al: 2022 ESC guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J 2022; 43(41):4229-4361.
  2. Salem JE, Yang T, Moslehi JJ, et al: Androgenic effects on ventricular repolarization: a translational study from the international pharmacovigilance database to iPSC-cardiomyocytes. Circulation 2019; 140(13):1070-1080. PubMed
  3. Product Information: VANTAS® subcutaneous implant, histrelin acetate subcutaneous implant. Endo Pharmaceuticals Solutions Inc, Malvern, PA, 2026. DailyMed
Was this write-up helpful?

Other Serious Interactions of Dolasetron Injection and Histrelin

Also serious with Dolasetron Injection

Also serious with Histrelin

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, as soon as they can.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together.
  • Major Potentially serious — often needs a change or close monitoring. This interaction.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized. This interaction.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.